A reported potent and selective reversible MAGL inhibitor fails to reproduce its claimed potency in two established in vitro assays, even when the previously reported substrate is used, while eight related analogs are likewise inactive. The findings highlight substantial assay‐dependent behavior and the need for careful validation before such compounds
Juha R. Savinainen +3 more
wiley +1 more source
Cannabis sativa phytochemicals in cancer therapy: molecular mechanisms and therapeutic potential. [PDF]
Montle R, More GK, Takaidza S, Mtunzi F.
europepmc +1 more source
Retraction Notice to: Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β. [PDF]
Li LT +13 more
europepmc +1 more source
Direct modulation of human GABA-A α<sub>1</sub>β<sub>2</sub>γ<sub>2</sub> receptors by the endocannabinoid 2-arachidonoylglycerol: implications for cannabinoid-related ligands and limitations for anxiolytic drug development. [PDF]
Mixcoha E +4 more
europepmc +1 more source
Targeting cannabinoid receptor 1 for multiple sclerosis: molecular docking and dynamic insights of berberine and curcumin as potential therapeutic agents. [PDF]
Alrahimi J.
europepmc +1 more source
Regulation and Use of Cannabidiol in Croatia Compared with Selected European and International Models: From Consumer Products to Clinical Practice. [PDF]
Batinic A, Zecic A, Dujic Z, Sutlovic D.
europepmc +1 more source
Therapeutic Use of Medical Cannabis Beyond Pain Management in Physical Medicine and Rehabilitation. [PDF]
Cameron A, Fraix MP, Agrawal DK.
europepmc +1 more source
Dimethylindanoylindole Isomers Revealed Different Pharmacological Profiles at CB1 and CB2 Cannabinoid Receptors. [PDF]
Oh SJ +8 more
europepmc +1 more source
Quantifying Heteromer Partitioning Reveals Inflammation-Dependent Redistribution of Microglial Adenosine A<sub>2A</sub> and Cannabinoid CB<sub>2</sub> Receptors. [PDF]
Franco R +4 more
europepmc +1 more source

